speb/financial-data huggingface dataset:
MANE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -2428000.00
MANE cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 4360000.00
MANE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1499000.00
MANE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 251000.00
MANE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 146646000.00
MANE balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
MANE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 390640000.00
MANE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 269102000.00
MANE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 5606000.00
MANE balance_sheet (quarterly, 2026-03-31) — Current Assets: 397069000.00
MANE balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6716000.00
MANE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 22704124.00
MANE income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.32
MANE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -30011000.00
MANE income_statement (quarterly, 2026-03-31) — EBIT: -29713000.00
MANE income_statement (quarterly, 2026-03-31) — EBITDA: -29713000.00
MANE cash_flow (quarterly, 2026-03-31) — End Cash Position: 168412000.00
MANE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 269113000.00
MANE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -21168000.00
MANE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -524000.00
MANE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 8937000.00
MANE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 287000.00
MANE income_statement (quarterly, 2026-03-31) — Interest Income: 2481000.00
MANE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2481000.00
MANE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 390640000.00
MANE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -101299000.00
MANE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 269102000.00
MANE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
MANE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 269102000.00
MANE income_statement (quarterly, 2026-03-31) — Net Income: -27232000.00
MANE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -30011000.00
MANE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -27232000.00
MANE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -27232000.00
MANE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -27232000.00
MANE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -27232000.00
MANE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -27232000.00
MANE income_statement (quarterly, 2026-03-31) — Net Interest Income: 2481000.00
MANE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -101299000.00
MANE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 2481000.00
MANE balance_sheet (quarterly, 2026-03-31) — Net PPE: 287000.00
MANE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
MANE cash_flow (quarterly, 2026-03-31) — Net Preferred Stock Issuance: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 390640000.00
MANE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -29713000.00
MANE income_statement (quarterly, 2026-03-31) — Normalized Income: -27232000.00
MANE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -21168000.00
MANE income_statement (quarterly, 2026-03-31) — Operating Income: -29713000.00
MANE income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 37340290.00
MANE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 602000.00
MANE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 39000.00
MANE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -524000.00
MANE balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -1228000.00
MANE income_statement (quarterly, 2026-03-31) — Other Gand A: 8937000.00
MANE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 554000.00
MANE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -149000.00
MANE balance_sheet (quarterly, 2026-03-31) — Other Properties: 287000.00
MANE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 222385000.00
MANE balance_sheet (quarterly, 2026-03-31) — Payables: 1071000.00
MANE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6677000.00
MANE balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
MANE income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 2779000.00
MANE cash_flow (quarterly, 2026-03-31) — Preferred Stock Issuance: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 4019000.00
MANE income_statement (quarterly, 2026-03-31) — Pretax Income: -27232000.00
MANE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 11000.00
MANE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -122988000.00
MANE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Receivables: 1651000.00
MANE income_statement (quarterly, 2026-03-31) — Research And Development: 20925000.00
MANE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -150653000.00
MANE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 21689000.00
MANE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 8937000.00
MANE balance_sheet (quarterly, 2026-03-31) — Share Issued: 37340290.00
MANE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 5259000.00
MANE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 390640000.00
MANE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 390640000.00
MANE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MANE income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
MANE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1213000.00
MANE balance_sheet (quarterly, 2026-03-31) — Total Assets: 397356000.00
MANE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 390640000.00
MANE balance_sheet (quarterly, 2026-03-31) — Total Debt: 0.00
MANE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 390640000.00
MANE income_statement (quarterly, 2026-03-31) — Total Expenses: 29713000.00
MANE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6716000.00
MANE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 287000.00
MANE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MANE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -29862000.00
MANE balance_sheet (quarterly, 2026-03-31) — Working Capital: 390353000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3363330000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 198105000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -29314000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Amortization: 4227000.00
MANGLMCEM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 4227000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 27497298.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Basic EPS: 28.26
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1861501000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 651365000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 70222000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 27497298.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Diluted EPS: 28.26
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 1772000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 201322000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 29385000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 395471000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Interest Income: 114441000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 114441000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1313247000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 11463420000.00
MANGLMCEM.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -100000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 599445000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 209646000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 204025000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 700000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 47429000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 96629000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Other Special Charges: -3371000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 122932000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1784796000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Properties: 135209000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1265825000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 39757000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 39757000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 13146000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 5094000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 6295296000.00
MANGLMCEM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 161848000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 3724000.00
MANGLMCEM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 565486000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 7347722000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 17921756000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 2633352000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 369983000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4038936000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 198105000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -28700000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Amortization: 4027000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 4027000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1903000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 27497298.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Basic EPS: 6.23
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 651365000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 2131505000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1271617000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 99355000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 507843000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2137781000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -41246000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 210000000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 297843000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -534890000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 584528000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -8204000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 41434000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -143522000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 7562227000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 903420000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 9747915000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 6691557000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 21938000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 3206284000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 3228222000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 0.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 7790374000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 567810000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Depreciation: 690695000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 694722000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 694722000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 690695000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 27497298.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 6.23
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 171230000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 1486000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — EBIT: 681007000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — EBITDA: 1375729000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 507843000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -894352000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 948389000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 114808000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -90229000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -5568000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 77839000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 280000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 398683000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 16641206000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 8173841000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 0.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 403800000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 403800000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Interest Income: 58673000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 58673000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -721628000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 95658000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 2568223000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 13677511000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -635595000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1903000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 700091000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1313247000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 77417000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 2909000000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2986417000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 700091000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1454644000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 114164000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 12157825000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 5607441000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Income: 171230000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 171230000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 171230000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 171230000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 171230000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 277207000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 171230000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -602926000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 350187000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -101794000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -754553000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -602926000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -271000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 12602270000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1251440000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 652759000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 7561947000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 603617000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 640754000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 201876000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 444008000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1477882000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 234329626.60
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1386425000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Operating Income: 826119000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 17921756000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 27497298.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1304003000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 315285000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 7287253000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 280000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 700000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 604596000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 196074000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1340878000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 478566000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 11605867000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 146905000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1629938000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: 188941000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Payables: 3113404000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 161691000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1274031000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 277207000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Properties: 135209000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -613000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -891240000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1271617000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1270061000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 9747915000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 694722000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 43809000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 43809000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1454644000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 68012000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 0.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 6435924000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 1241427000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 20177000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 4148671000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 4226510000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 27497298.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -190712000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 7562227000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 7561947000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -39053373.40
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 105977000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.38
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 126622000.00
MANGLMCEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -135124000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 19901805000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 10471227000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 6214639000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 7562227000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 17095637000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 12339578000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 13210248000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 4549204000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 257799000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -102153000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -102153000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 2377000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 349073000.00
MANGLMCEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: -1098817000.00
MANGLMCEM.NS income_statement (annual, 2023-03-31) — Write Off: 1771000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 13113606000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 17245795000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 2476941000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 344811000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -4772968000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 198105000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -28577000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Amortization: 3993000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 3993000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 1742000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 27497298.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 21.72
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 507843000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 2581194000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -987473000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 80643000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 355239000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 2163798000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -41246000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 355239000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -507770000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 121979000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 140152000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -245639000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -152604000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 8116171000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1215088000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 2829067000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 6965218000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 23656000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 3545522000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 3569178000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 64776000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 8236210000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 628352000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 738137000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 742130000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 742130000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 738137000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 27497298.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 21.72
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 597166000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 1580000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — EBIT: 1481865000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — EBITDA: 2223995000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 355239000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -858848000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 808070000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 837110000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -92958000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 2150000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 99438000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 202000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 373388000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 17604020000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 14416728000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: -30432000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 490760000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 490760000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Interest Income: 136156000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 136156000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -690838000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 98108000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 3075993000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 14110313000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1118339000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 1742000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 706313000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1314801000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 56987000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 2448620000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 2505607000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 706313000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1099233000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 127864000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 12357728000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 5638903000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Income: 597166000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 597166000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 597166000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 597166000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 597166000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 991105000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 597166000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -539650000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -232243000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -94756000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -392920000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -539650000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 12831052000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -984204000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 298164000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 8115969000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 629324000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 859389000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 202350000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 737930000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2124157000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 537011062.72
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1824583000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Operating Income: 1303122000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 17245795000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 27497298.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1032365000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 593394000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 7841197000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 202000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 700000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 511771000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1425762000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -1000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 107624000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 6818740000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 349771000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 11526895000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 49793000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1808559000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: 2150000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Payables: 2828292000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 226869000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1006700000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 991105000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Properties: 135209000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 0.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -232243000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -987473000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1301150000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 2829067000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 742130000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 43268000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 43268000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1099233000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 226106000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 6989144000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 0.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 3269000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 4129318000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 4228756000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 27497298.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 9433000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 8116171000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 8115969000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 39683062.72
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 393939000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.40
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 98017000.00
MANGLMCEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -83976000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 20679009000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 10564791000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 6074785000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 8116171000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 15942673000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 12562838000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 13713791000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 4326628000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 185046000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 64776000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 99838000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 99838000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 2095000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 966073000.00
MANGLMCEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: -1270992000.00
MANGLMCEM.NS income_statement (annual, 2024-03-31) — Write Off: 18849000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2034865000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 340829000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 122598000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 131428000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 248731000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2612820000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 8279930000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 113380000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 7251718000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 20106000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 4222439000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 4242545000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 8234002000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 336048000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 87272000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 11712666000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 3179525000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 14610213000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 122598000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 111322000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 2107844000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 2219166000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 330884000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 6081552000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 11712666000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 8192658000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 902358000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 27497298.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1048031000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 1039853000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 8004957000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 87272000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1470614000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 206841000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 11599286000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 2364089000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2128397000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 27497298.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 8279930000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 8192658000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 70513000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 20675300000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 10387774000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 6461711000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 8279930000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 12395370000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 13423582000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 4161368000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 93532000.00
MANGLMCEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -982284000.00
MANGLMCEM.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
MANGLMCEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
MANGLMCEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 12937785000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 3339519000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 16809878000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 5028964000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2563225000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2563225000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 397196000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 397196000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5373429000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5373429000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 198105000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 198105000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -29270000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -29270000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Amortization: 3986000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 3986000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 28255000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 28255000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 27494265.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 27493821.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 16.39
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 6.15
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 355239000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 2752393000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 2752393000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1254067000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 123974000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 123974000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 285471000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 285471000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1955375000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1955375000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -41246000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 285471000.00